发明名称 TOPICAL PHARMACEUTICAL COMPOSITION
摘要 There is provided a topical pharmaceutical composition comprising the following components and percentages: ester of salicylic or nicotinic acid - 10-20%; menthol - 5-10%; lower alcohol - 15-35%; water - 10-20%; propylene glycol and/or pentane-1,5-diol - 15-35%; hydrophilic pharmaceutically-acceptable non-volatile non-solvent for menthol - 2-16%; and, optionally, up to 5% camphor, all percentages being by weight. Also provided is a topical pharmaceutical composition comprising a volatile phase and a non-volatile phase, the non- volatile phase comprising from 32-81% of the total composition by weight, and comprising the following non-volatile constituents, expressed as % weight of the non-volatile phase: ester of salicylic or nicotinic acid - 14-48 %; menthol - 7-27 %; propylene glycol and/or pentane-1,5-diol - 25-67 %; hydrophilic pharmaceutically-acceptable non-volatile non- solvent for menthol - 3-35 %, and a concentrate comprising the non-volatile components of this composition. The compositions are useful in the treatment or prevention of pain.
申请公布号 WO2015079233(A1) 申请公布日期 2015.06.04
申请号 WO2014GB53510 申请日期 2014.11.27
申请人 FUTURA MEDICAL DEVELOPMENTS LIMITED 发明人 DAVIS, ADRIAN
分类号 A61K9/00;A61K31/045;A61K31/455;A61K31/60;A61K47/10;A61K47/32 主分类号 A61K9/00
代理机构 代理人
主权项
地址